Key Drivers of 2025 Health Care Cost Increases

Healthcare costs are projected to rise significantly in 2025, continuing a multi-year trend of compounding increases. Estimates suggest that healthcare spending in the United States will grow by 7%-8%, mirroring 2024’s growth trajectory. Large employers predict a 7.8% rise in health care costs before plan design changes, with a median 8% increase estimated overall. Understanding the key factors behind these increases is essential for employers and employees alike.

GLP-1 Medications

A major contributor to rising health care costs is the growing demand for glucagon-like peptide-1 (GLP-1) drugs. These medications, initially approved for type 2 diabetes, are now widely used for weight loss and show promise for treating conditions such as Alzheimer’s disease, heart disease, and sleep apnea. Popular GLP-1 drugs like Mounjaro, Ozempic, and Wegovy typically cost around $1,000 per month and are intended for long-term use, adding to their financial impact.

Currently, around 1 in 8 Americans have used a GLP-1 drug, and 6% are actively taking one. This number is expected to rise, with projections indicating that 9% of the U.S. population could be using GLP-1s by 2030. This growing utilization underscores the significant role GLP-1s play in driving healthcare spending.

General Pharmacy Spend

Beyond GLP-1s, other factors contributing to rising pharmacy costs include:

• Existing Drug Cost Increases: Commonly used drugs such as demosumab and dupilumab are expected to see price hikes of 4%-10% or more, compounded by increased utilization.
• Cell and Gene Therapies (CGT): Advanced treatments for conditions like cancer and sickle cell anemia are highly effective but expensive, costing between $250,000 and $4.25 million per dose. By 2025, nearly 100,000 U.S. patients may be eligible for CGT, potentially adding $25 billion to health care costs.
• Biologics and Biosimilars: Biologics, while effective for treating complex conditions, are expensive and account for 37% of net drug spending despite comprising only 2% of prescriptions. Biosimilars, lower-cost alternatives, have the potential to save billions but face challenges such as exclusivity rights and slow market adoption.

Health Care Labor Costs

The healthcare labor market is another significant driver of cost increases. Rising wages, inflation, and a growing demand for services—driven by an aging population—have led to higher operational expenses for healthcare providers. These costs are often passed on to employers and employees.

Chronic Health Conditions

Chronic diseases account for approximately 90% of U.S. healthcare spending. Conditions such as heart disease, stroke, diabetes, and obesity are prevalent and costly. For example:

• Cardiovascular Diseases: Expected to affect over 60% of U.S. adults by 2050, with related costs tripling to $1.8 trillion.
• Obesity: Over 40% of U.S. adults have obesity, contributing to increased costs for associated conditions like diabetes and sleep apnea. In 2019, obesity-related medical care costs were estimated at nearly $173 billion.

Aging Populations

An aging U.S. population further exacerbates healthcare costs. Adults aged 65 and older use health care more frequently, with per-person spending five times higher than that for children and 2.5 times higher than for working-age adults. By 2040, nearly 80 million Americans will be aged 65 or older, amplifying the financial strain on the health care system.

Employer Takeaway

Providing quality health care benefits is a significant financial commitment for employers, often shared with employees. While rising costs may be unavoidable, understanding these trends enables employers to make informed decisions and explore strategies to mitigate financial impacts. Employers should consider innovative plan designs, wellness initiatives, and employee education to address these challenges effectively. Reach out to BenePro of Royal Oak, MI so we can help you with your employee benefit needs.